Y
Yashas
About Yashas
Data last updated:
Yashas is a Director at Vipragen Biosciences Private Limited (since 2021), Director at Collectis Health Solutions Private Limited (since 2023) and Director at Cypa Therapeutics Private Limited (since 2022). The companies operate in Pharma, Professional Services and Research & Development. The largest current company by reported revenue is Vipragen Biosciences Private Limited at ₹18.35 Cr (FY 2025). Earlier, Yashas was an Additional Director at Genei Laboratories Private Limited (2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vipragen Biosciences Private Limited U73100KA2012PTC063955 | Director | 10 Feb 2021 | 2012 | ₹18.35 Cr (FY 2025) | Active |
 Collectis Health Solutions Private Limited U72100KA2023PTC177088 | Director | 08 Aug 2023 | 2023 | Active | |
| Cypa Therapeutics Private Limited U73100KA2022PTC162124 | Director | 06 Jun 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genei Laboratories Private Limited U24233KA2013PTC067508 | Additional Director | 03 Aug 2020 | 2013 | ₹9.23 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Yashas
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kannasandra Pushpalatha | 01683405 | Vipragen Biosciences Private Limited , Cypa Therapeutics Private Limited | Director |
| Pallavur Viswanathan Harikrishnan | 10339546 | Vipragen Biosciences Private Limited | Nominee Director |
| Patlapati Harsha Samaraditya | 11266474 | Vipragen Biosciences Private Limited | Additional Director |
| Siddamadappa Chandrashekaran | 01770678 | Vipragen Biosciences Private Limited | Managing Director |
| Umesh Devurkar | 06382944 | Vipragen Biosciences Private Limited | Director |
| Sarvadeep Singh | 09783285 | Collectis Health Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yashas
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yashas
Yashas currently holds 3 directorships: Vipragen Biosciences Private Limited (Director, since 10 Feb 2021, revenue ₹18.35 Cr (FY 2025)); Collectis Health Solutions Private Limited (Director, since 08 Aug 2023); Cypa Therapeutics Private Limited (Director, since 06 Jun 2022).
Yashas was first appointed on 03 Aug 2020 as Additional Director at Genei Laboratories Private Limited. The most recent appointment on record is 08 Aug 2023 at Collectis Health Solutions Private Limited.
Yashas held 1 earlier board appointment: Genei Laboratories Private Limited (Additional Director, 03 Aug 2020 to 21 Nov 2020).
The current boards of Yashas's companies include Kannasandra Pushpalatha (Vipragen Biosciences Private Limited), Pallavur Viswanathan Harikrishnan (Vipragen Biosciences Private Limited), Patlapati Harsha Samaraditya (Vipragen Biosciences Private Limited), Siddamadappa Chandrashekaran (Vipragen Biosciences Private Limited), Umesh Devurkar (Vipragen Biosciences Private Limited), Sarvadeep Singh (Collectis Health Solutions Private Limited).